glp-1 trends Receptor Agonist Market Size Recent Trends in GLP-1 Use
Description
Except oral semaglutide, GLP-1 RAs are administered subcutaneously, particularly those with proven CV benefits
It is $100 less than Novo, which launched its pill in January at $149 for first-time users and $199 after that
Diabetes Obes Metab 2017;19:52436.PubMed 64
95% CI, 1.15 to 1.26) and diabetic macular edema (HR, 1.13
ListerNBBaurLAFelixJFHillAJMarcusCReinehrTet alChild and adolescent obesity
1 (1993): 301307, 10.1172/JCI116186
